Track Avax Technologies's receivables ($44K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2008), AVXT shows a receivables of $44K. That compares with $160K in the prior-year period — down 73.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AVXT's receivables is now $44K (was $160K) — a 73.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Avax Technologies is outperforming or lagging.
Tracking AVXT's receivables over time shows whether Avax Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $44K That compares with $160K in the prior-year period — down 73.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Avax Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $44K) with ownership activity and broader fundamentals.
Avax Technologies's receivables is $44K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.